Erratum to: Anti-inflammatory effects of N1-Benzyl-4-methylbenzene-1,2-diamine (JSH-21) analogs on nitric oxide production and nuclear factor-kappa B transcriptional activity in lipopolysaccharide-stimulated macrophages RAW 264.7 (Archives of Pharmacal Research, (2004), 27, 10, (1053-1059), 10.1007/BF02975431);Anti-inflammatory effects of N1-benzyl-4-methylbenzene-1,2- diamine (JSH-21) analogs on nitric oxide production and nuclear factor-kappa B transcriptional activity in lipopolysaccharide-stimulated macrophages RAW 264.7

Archives of Pharmacal Research

Volumn 27, Issue 10, 2004, Pages 1053-1059

  Kyung, Rak Min ^a   Shin, Hyun Mo ^a   Lee, Jee Hyun ^b   Byung, Hak Kim ^a   Eun, Yong Chung ^a   Jung, Sang Hun ^b   Kim, Youngsoo ^a  

^a Chungbuk National University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Anti inflammatory effect; Chemical preparation; Lipopolysaccharide; N1 Benzyl 4 methylbenzene 1,2 diamine; Nitric oxide; Nuclear factor kappa B

Indexed keywords

AMINE; BENZYL DERIVATIVE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N1 BENZYL 4 METHYLBENZENE 1,2 DIAMINE; N1-BENZYL-4-METHYLBENZENE-1,2-DIAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; NOS2A PROTEIN, HUMAN;

ARTICLE; BIOSYNTHESIS; CELL LINE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AMINES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZYL COMPOUNDS; CELL LINE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION, GENETIC;

EID: 16644392901     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02975127     Document Type: Erratum

References (29)

1. Archer, S., Measurement of nitric oxide in biological models. FASEB J., 7, 349-360 (1993).
2. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M., Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science, 270, 286-290 (1995).
3. Baeuerle, P. A. and Baltimore, D., NF-kappa B: ten years after. Cell, 87, 13-20 (1996).
4. Beg, A. A., Ruben, S. M., Scheinman, R. I., Haskill, S., Rosen, C. A., and Baldwin, A. S. Jr., I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev., 6, 1899-1913 (1992).
5. Blantz, R. C. and Munger, K., Role of nitric oxide in inflammatory conditions. Nephron, 90, 373-378 (2002).
6. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol., 2, 907-916 (2001).
7. Brown, S. A. and Rizzo, C. J., A "one-pot" phase transfer alkylation/hydrolysis of o-nitrotrifluoroacetanilides. a convenient route to N-alkyl o-phenylenediamines. Synthet. Commun., 26, 4065-4080 (1996).
8. Cavaillon, J. M., Adib-Conquy, M., Fitting, C., Adrie, C., and Payen, D., Cytokine cascade in sepsis. Scand. J. Infect. Dis., 35, 535-544 (2003).
9. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., and Maniatis, T., Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J., 9, 899-909 (1995).
10. Dick, L. R., Cruikshank, A. A., Destree, A. T., Grenier, L., McCormack, T. A., Melandri, F. D., Nunes, S. L., Palombella, V. J., Parent, L. A., Plamondon, L., and Stein, R. L., Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem., 272, 182-188 (1997).
11. Hehner, S. P., Hofmann, T. G., Droge, W., and Schmitz, M. L., The anti-inflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J. Immunol., 163, 5617-5623 (1999).
12. Ignarro, L. J., Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J. Physiol. Pharmacol., 53, 503-514 (2002).
13. Jones, B. W., Means, T. K., Heldwein, K. A., Keen, M. A., Hill, P. J., Belisle, J. T., and Fenton, M. J., Different Toll-like receptor agonists induce distinct macrophage responses. J. Leukoc. Biol., 69, 1036-1044 (2001).
14. Liaudet, L., Soriano, F. G., and Szabo, C., Biology of nitric oxide signaling. Crit. Care Med., 28, N37-N52 (2000).
15. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., and Murphy, W. J., Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc. Natl. Acad. Sci. U.S.A., 90, 9730-9734 (1993).
16. MacMicking, J., Xie, Q. W., and Nathan, C., Nitric oxide and macrophage function. Annu. Rev. Immunol., 15, 323-350 (1997).
17. Manna, S. K., Bueso-Ramos, C., Alvarado, F., and Aggarwal, B. B., Calagualine inhibits nuclear transcription factors-kappaB activated by various inflammatory and tumor promoting agents. Cancer Lett., 190, 171-182 (2003).
18. Moon, K. Y., Hahn, B. S., Lee, J., and Kim, Y. S., A cell-based assay system for monitoring NF-kappaB activity in human HaCat transfectant cells. Anal. Biochem., 292, 17-21 (2001).
19. Moreland, L. W., Drugs that block tumor necrosis factor: experience in patients with rheumatoid arthritis. Pharmacoeconomics, 22, 39-53 (2004).
20. Palmer, R. M., Ashton, D. S., and Moncada, S., Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664-666 (1988).
21. Paramore, A. and Frantz, S., Bortezomib. Nat. Rev. Drug Discov., 2, 611-612 (2003).
22. Perrin, D. D., Armarego, W. L. F., and Perrin, D. R., Purification of Laboratory Chemicals, 2nd ed. Pergamon Press, Oxford (1982).
23. Prast, H. and Philippu, A., Nitric oxide as modulator of neuronal function. Prog. Neurobiol., 64, 51-68 (2001).
24. Sherman, M. P., Aeberhard, E. E., Wong, V. Z., Griscavage, J. M., and Ignarro, L. J., Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem. Biophys. Res. Commun., 191, 1301-1308 (1993).
25. Tian, B. and Brasier, A. R., Identification of a nuclear factor kappa B-dependent gene network. Recent Prog. Horm. Res., 58, 95-130 (2003).
26. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S., Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev., 9, 2723-2735 (1995).
27. Xie, Q. W., Whisnant, R., and Nathan, C., Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med., 177, 1779-1784 (1993).
28. Yuste, F., Saldana, M., and Walls, F., Selective reduction of aromatic nitrounds containing O- and N-benzyl groups with hydrazine and Raney nickel. Tetrahedron Lett., 23, 147-148 (1982).
29. Zafarullah, M., Li, W. Q., Sylvester, J., and Ahmad, M., Molecular mechanisms of N-acetylcysteine actions. Cell Mol. Life Sci., 60, 6-20 (2003).